Previous close | 0.5900 |
Open | 0.6000 |
Bid | 0.5806 x 100 |
Ask | 0.6458 x 100 |
Day's range | 0.5851 - 0.6479 |
52-week range | 0.5000 - 8.2500 |
Volume | |
Avg. volume | 289,580 |
Market cap | 30.488M |
Beta (5Y monthly) | 1.56 |
PE ratio (TTM) | 1.02 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced that it had had received a staff determination letter on May21, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that, due to the Company's non-compliance w
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in nine states and primary care-centric, risk-bearing physician networks, today announced first quarter 2024 financial results for the three months ended March 31, 2024.
Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 21 state-of-the-art micro hospitals in 9 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the first quarter ended March 31, 2024 after the close of the stock market on Wednesday, May 8, 2024. The Company will discuss those results on a conference call on Friday, May 10